Heterogeneous delivery is a barrier to the translational advancement of oncolytic virotherapy for treating solid tumors

Amber C. Miller, Stephen J. Russell

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Fingerprint Dive into the research topics of 'Heterogeneous delivery is a barrier to the translational advancement of oncolytic virotherapy for treating solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences